Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Arrhythmias

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 49 articles:
HTML format



Single Articles


    June 2021
  1. KOVACS MJ, Wells PS, Anderson DR, Lazo-Langner A, et al
    Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
    BMJ. 2021;373:n1205.
    PubMed     Abstract available


    May 2021
  2. PERRY M, Kemmis Betty S, Downes N, Andrews N, et al
    Atrial fibrillation: diagnosis and management-summary of NICE guidance.
    BMJ. 2021;373:n1150.
    PubMed    


  3. KIM D, Yang PS, You SC, Sung JH, et al
    Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study.
    BMJ. 2021;373:n991.
    PubMed     Abstract available


    April 2021
  4. PONAMGI SP, Siontis KC, Rushlow DR, Graff-Radford J, et al
    Screening and management of atrial fibrillation in primary care.
    BMJ. 2021;373:n379.
    PubMed     Abstract available


    September 2020
  5. UITTENBOGAART SB, Verbiest-van Gurp N, Lucassen WAM, Winkens B, et al
    Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial.
    BMJ. 2020;370:m3208.
    PubMed     Abstract available


    August 2020
  6. VINTER N, Huang Q, Fenger-Gron M, Frost L, et al
    Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): community based cohort study.
    BMJ. 2020;370:m2724.
    PubMed     Abstract available


    February 2020
  7. KAPELIOS CJ, Bonou M, Barbetseas J, Makrilakis K, et al
    An unexpected finding on a chest radiograph.
    BMJ. 2020;368:m426.
    PubMed    


    January 2020
  8. MOHANAN NAIR KK, Namboodiri N, Valaparambil A
    Syncope in a young woman.
    BMJ. 2020;368:l6877.
    PubMed    


  9. MAHASE E
    NICE recommends implantable monitor to identify atrial fibrillation after stroke.
    BMJ. 2020;368:m133.
    PubMed    


    November 2019
  10. BHATTI A, Oakeshott P, Dhinoja M, Grapsa J, et al
    Ablation therapy in atrial fibrillation.
    BMJ. 2019;367:l6428.
    PubMed    


    October 2019
  11. MIRZAZADEH M, Alijani E, Fani M, Jamili S, et al
    A 44 year old woman with episodic sweating and hypertension.
    BMJ. 2019;367:l5879.
    PubMed    


    July 2019
  12. MAHASE E
    Atrial fibrillation groups lobby patients to overturn screening committee decision.
    BMJ. 2019;366:l4612.
    PubMed    


    June 2019
  13. STEELE R, Marshall J, Mackie A
    Screening for atrial fibrillation: waiting for randomised trial data.
    BMJ. 2019;365:l2383.
    PubMed    


    April 2019
  14. BERGE T
    Wilson and Jungner would not approve of screening for atrial fibrillation.
    BMJ. 2019;365:l1416.
    PubMed    


    March 2019
  15. MACFADYEN RJ
    Screening for atrial fibrillation: one size does not fit all.
    BMJ. 2019;364:l1396.
    PubMed    


  16. MAYOR S
    Catheter ablation for atrial fibrillation no better than drug therapy for reducing death or disabling stroke, trial finds.
    BMJ. 2019;364:l1254.
    PubMed    


    February 2019
  17. IZAWA J, Komukai S, Gibo K, Okubo M, et al
    Pre-hospital advanced airway management for adults with out-of-hospital cardiac arrest: nationwide cohort study.
    BMJ. 2019;364:l430.
    PubMed     Abstract available


  18. LOWN M, Moran P
    Should we screen for atrial fibrillation?
    BMJ. 2019;364:l43.
    PubMed    


    October 2018
  19. ABRAHAM G, Ghazanfar MA, Bajpai A
    An unusual cause of shortness of breath and palpitations.
    BMJ. 2018;363:k3883.
    PubMed    


  20. ZUNGSONTIPORN N, Link MS
    Newer technologies for detection of atrial fibrillation.
    BMJ. 2018;363:k3946.
    PubMed     Abstract available


  21. MARRIOTT C, George C
    New onset atrial fibrillation, prominent chest wall veins, and dyspnoea.
    BMJ. 2018;363:k3779.
    PubMed    


    July 2018
  22. VINOGRADOVA Y, Coupland C, Hill T, Hippisley-Cox J, et al
    Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care.
    BMJ. 2018;362:k2505.
    PubMed     Abstract available


    May 2018

  23. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    BMJ. 2018;361:k2295.
    PubMed    


  24. SILVERWOOD RJ, Forbes HJ, Abuabara K, Ascott A, et al
    Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study.
    BMJ. 2018;361:k1786.
    PubMed     Abstract available


  25. ADDERLEY NJ, Nirantharakumar K, Marshall T
    Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies.
    BMJ. 2018;361:k1717.
    PubMed     Abstract available


  26. GRECH ED, Zwart B
    A man with chest pain and a broad QRS complex tachycardia.
    BMJ. 2018;361:k1191.
    PubMed    


    April 2018
  27. STAERK L, Wang B, Preis SR, Larson MG, et al
    Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.
    BMJ. 2018;361:k1453.
    PubMed     Abstract available


    March 2018
  28. HONARBAKHSH S, Hunter L, Chow A, Hunter RJ, et al
    Bradyarrhythmias and pacemakers.
    BMJ. 2018;360:k642.
    PubMed    


    February 2018
  29. KUMAR S, de Lusignan S, McGovern A, Correa A, et al
    Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
    BMJ. 2018;360:k342.
    PubMed     Abstract available


    January 2018
  30. ADELBORG K, Szepligeti SK, Holland-Bill L, Ehrenstein V, et al
    Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.
    BMJ. 2018;360:k96.
    PubMed     Abstract available


  31. HUNT BJ, Levi M
    Urgent reversal of vitamin K antagonists.
    BMJ. 2018;360:j5424.
    PubMed    


    December 2017

  32. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    BMJ. 2017;359:j5631.
    PubMed    


    November 2017
  33. LOPEZ-LOPEZ JA, Sterne JAC, Thom HHZ, Higgins JPT, et al
    Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    BMJ. 2017;359:j5058.
    PubMed     Abstract available


  34. BALL J
    Which anticoagulant for stroke prevention in atrial fibrillation?
    BMJ. 2017;359:j5399.
    PubMed    


  35. CHATTERJEE D
    A young man with palpitations and pre-syncope.
    BMJ. 2017;359:j4846.
    PubMed    


    October 2017
  36. MAYOR S
    Men develop atrial fibrillation 10 years earlier than women, finds study.
    BMJ. 2017;359:j4802.
    PubMed    


  37. FLOYD CN, Ferro A
    Indications for anticoagulant and antiplatelet combined therapy.
    BMJ. 2017;359:j3782.
    PubMed    


    September 2017
  38. TORJESEN I
    Over 15% of atrial fibrillation patients are not prescribed any antithrombotic agent for stroke prevention by GPs.
    BMJ. 2017;358:j4467.
    PubMed    


    July 2017
  39. ABI KHALIL C, Haddad F, Al Suwaidi J
    Investigating palpitations: the role of Holter monitoring and loop recorders.
    BMJ. 2017;358:j3123.
    PubMed    


    June 2017
  40. DAVIES RH, Thomas DE
    Heart rhythm conundrum.
    BMJ. 2017;357:j2215.
    PubMed    


    May 2017
  41. CHATTERJEE D
    A case of palpitation and pre-syncope.
    BMJ. 2017;357:j2343.
    PubMed    


  42. HIPPISLEY-COX J, Coupland C, Brindle P
    Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    BMJ. 2017;357:j2099.
    PubMed     Abstract available


  43. MILLER EO, Krishnamoorthy VK, Ling FSK, Chaturvedi A, et al
    A man with chest pain and acute ST elevations on electrocardiogram.
    BMJ. 2017;357:j2198.
    PubMed    


  44. YI Z, Huang YS, Wang L, Zhao YT, et al
    A man with chest tightness and burning limbs.
    BMJ. 2017;357:j1979.
    PubMed    


    November 2016
  45. MAYOR S
    More than half of stroke patients were not given preventive drugs, study finds.
    BMJ. 2016;355:i6105.
    PubMed    


  46. SUKKAR L, Hong D, Wong MG, Badve SV, et al
    Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis.
    BMJ. 2016;355:i5599.
    PubMed     Abstract available


    October 2016
  47. MOORE TJ
    Optimal dosing of rivaroxaban is undefined.
    BMJ. 2016;355:i5549.
    PubMed    


  48. TORJESEN I
    Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows.
    BMJ. 2016;355:i5362.
    PubMed    


    August 2016
  49. WISE J
    Most patients taking warfarin do not maintain stable INR values.
    BMJ. 2016;354:i4402.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: